aluates Reports

$ 0.0

Automative

Global Open-Angle Glaucoma Therapeutics Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-30H13902

Global Open Angle Glaucoma Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Open-Angle Glaucoma Therapeutics Market Research Report 2024

Code: QYRE-Auto-30H13902

Report

January 2024

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aerie Pharmaceuticals Inc.

Allergan plc

Bausch Health Companies Inc.

Novartis

Pfizer Inc

Open-Angle Glaucoma Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Open-Angle Glaucoma Therapeutics Market

Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.

The global Open-Angle Glaucoma Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Open-Angle Glaucoma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Open-Angle Glaucoma Therapeutics.

Report Scope

The Open-Angle Glaucoma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Open-Angle Glaucoma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Open-Angle Glaucoma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Open-Angle Glaucoma Therapeutics Market Report

Report Metric	Details
Report Name	Open-Angle Glaucoma Therapeutics Market
CAGR	5%
Segment by Type	Prostaglandin Analogs (PGAs) Combination of PGAs Other
Segment by Application	Hospital Clinic Research Institute Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aerie Pharmaceuticals Inc., Allergan Plc, Bausch Health Companies, Inc., Novartis AG, Pfizer Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Open-Angle Glaucoma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Open-Angle Glaucoma Therapeutics Market report?

Ans: The main players in the Open-Angle Glaucoma Therapeutics Market are Aerie Pharmaceuticals Inc., Allergan Plc, Bausch Health Companies, Inc., Novartis AG, Pfizer Inc.

What are the Application segmentation covered in the Open-Angle Glaucoma Therapeutics Market report?

Ans: The Applications covered in the Open-Angle Glaucoma Therapeutics Market report are Hospital, Clinic, Research Institute, Other

What are the Type segmentation covered in the Open-Angle Glaucoma Therapeutics Market report?

Ans: The Types covered in the Open-Angle Glaucoma Therapeutics Market report are Prostaglandin Analogs (PGAs), Combination of PGAs, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Prostaglandin Analogs (PGAs)

1.2.3 Combination of PGAs

1.2.4 Other

1.3 Market by Application

1.3.1 Global Open-Angle Glaucoma Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Research Institute

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Open-Angle Glaucoma Therapeutics Market Perspective (2019-2030)

2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Region

2.2.1 Global Open-Angle Glaucoma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Open-Angle Glaucoma Therapeutics Market Dynamics

2.3.1 Open-Angle Glaucoma Therapeutics Industry Trends

2.3.2 Open-Angle Glaucoma Therapeutics Market Drivers

2.3.3 Open-Angle Glaucoma Therapeutics Market Challenges

2.3.4 Open-Angle Glaucoma Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue

3.1.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue

3.4 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio

3.4.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2023

3.5 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served

3.6 Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service

3.7 Date of Enter into Open-Angle Glaucoma Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Open-Angle Glaucoma Therapeutics Breakdown Data by Type

4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2025-2030)

5 Open-Angle Glaucoma Therapeutics Breakdown Data by Application

5.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2019-2030)

6.2 North America Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)

6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2019-2030)

7.2 Europe Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)

7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Open-Angle Glaucoma Therapeutics Market Size (2019-2030)

9.2 Latin America Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aerie Pharmaceuticals Inc.

11.1.1 Aerie Pharmaceuticals Inc. Company Detail

11.1.2 Aerie Pharmaceuticals Inc. Business Overview

11.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction

11.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)

11.1.5 Aerie Pharmaceuticals Inc. Recent Development

11.2 Allergan Plc

11.2.1 Allergan Plc Company Detail

11.2.2 Allergan Plc Business Overview

11.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction

11.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)

11.2.5 Allergan Plc Recent Development

11.3 Bausch Health Companies, Inc.

11.3.1 Bausch Health Companies, Inc. Company Detail

11.3.2 Bausch Health Companies, Inc. Business Overview

11.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction

11.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)

11.3.5 Bausch Health Companies, Inc. Recent Development

11.4 Novartis AG

11.4.1 Novartis AG Company Detail

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction

11.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)

11.4.5 Novartis AG Recent Development

11.5 Pfizer Inc.

11.5.1 Pfizer Inc. Company Detail

11.5.2 Pfizer Inc. Business Overview

11.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction

11.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)

11.5.5 Pfizer Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Aerie Pharmaceuticals Inc.

Allergan plc

Bausch Health Companies Inc.

Novartis

Pfizer Inc

List of Tables

Table 1. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Prostaglandin Analogs (PGAs)

Table 3. Key Players of Combination of PGAs

Table 4. Key Players of Other

Table 5. Global Open-Angle Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Open-Angle Glaucoma Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2019-2024)

Table 9. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2025-2030)

Table 11. Open-Angle Glaucoma Therapeutics Market Trends

Table 12. Open-Angle Glaucoma Therapeutics Market Drivers

Table 13. Open-Angle Glaucoma Therapeutics Market Challenges

Table 14. Open-Angle Glaucoma Therapeutics Market Restraints

Table 15. Global Open-Angle Glaucoma Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Open-Angle Glaucoma Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2023)

Table 18. Ranking of Global Top Open-Angle Glaucoma Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Open-Angle Glaucoma Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service

Table 22. Date of Enter into Open-Angle Glaucoma Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Aerie Pharmaceuticals Inc. Company Detail

Table 48. Aerie Pharmaceuticals Inc. Business Overview

Table 49. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product

Table 50. Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)

Table 51. Aerie Pharmaceuticals Inc. Recent Development

Table 52. Allergan Plc Company Detail

Table 53. Allergan Plc Business Overview

Table 54. Allergan Plc Open-Angle Glaucoma Therapeutics Product

Table 55. Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)

Table 56. Allergan Plc Recent Development

Table 57. Bausch Health Companies, Inc. Company Detail

Table 58. Bausch Health Companies, Inc. Business Overview

Table 59. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product

Table 60. Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Bausch Health Companies, Inc. Recent Development

Table 62. Novartis AG Company Detail

Table 63. Novartis AG Business Overview

Table 64. Novartis AG Open-Angle Glaucoma Therapeutics Product

Table 65. Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Novartis AG Recent Development

Table 67. Pfizer Inc. Company Detail

Table 68. Pfizer Inc. Business Overview

Table 69. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product

Table 70. Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Pfizer Inc. Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Open-Angle Glaucoma Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Open-Angle Glaucoma Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Prostaglandin Analogs (PGAs) Features

Figure 4. Combination of PGAs Features

Figure 5. Other Features

Figure 6. Global Open-Angle Glaucoma Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Research Institute Case Studies

Figure 11. Other Case Studies

Figure 12. Open-Angle Glaucoma Therapeutics Report Years Considered

Figure 13. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Open-Angle Glaucoma Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Open-Angle Glaucoma Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Open-Angle Glaucoma Therapeutics Market Share by Players in 2023

Figure 17. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Open-Angle Glaucoma Therapeutics Revenue in 2023

Figure 19. North America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Region (2019-2030)

Figure 33. China Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Aerie Pharmaceuticals Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)

Figure 48. Allergan Plc Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)

Figure 49. Bausch Health Companies, Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)

Figure 50. Novartis AG Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)

Figure 51. Pfizer Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions